Cue Biopharma, Inc.
CUE· Nasdaq
Released Nov 9, 2020, after the close
10-Q filed Nov 9, 2020, 40 days after period end · 0001564590-20-052490
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $704.00K | $984.00K | $449.00K | — |
| Net Income | -$10.03M | -$6.99M | -$12.55M | -$5.03M |
| EPS Diluted | -$0.34 |
Cue Biopharma, Inc. · CIK 1645460 · Engraved from SEC EDGAR
| -$0.31 |
| -$0.62 |
| -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.